SCHEMBL23508682

SCHEMBL23508682

c1ccc2nc3c(cc2c1)CC1(CCNCC1)O3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GLA P06280 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ ACHE P22303 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23508680 0.77 OPRD1 (0.38) ALDH1A1MAPTGLAHPGDACHE
SCHEMBL23508683 0.76 OPRD1 (0.41) CYP2D6HTR2CHTR3EHTR3BSLC6A4
SCHEMBL29634711 0.72 HDAC3 (0.30) —
SCHEMBL24409009 0.72 HDAC3 (0.30) —
SCHEMBL29634730 0.70 CHRNB2 (0.43) ALDH1A1HPGDCYP3A4MAPK1HSD17B10
SCHEMBL13161926 0.70 CHRNB2 (0.43) ALDH1A1HPGDCYP3A4MAPK1HSD17B10
SCHEMBL231585 0.68 OPRD1 (0.49) CYP3A4KMT2AMEN1CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL10502202 0.67 OPRD1 (0.48) CYP3A4KMT2AMEN1CYP2D6CYP2C9
Acridine SCHEMBL27523545 0.66 ALDH1A1 (0.71) ALDH1A1MAPTGLAHPGDACHE
SCHEMBL22744378 0.66 MAPT (0.38) ALDH1A1MAPTGLAHPGDACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021115286-A1 SIX-MEMBERED AND FIVE-MEMBERED AROMATIC RING DERIVATIVE CONTAINING NITROGEN HETEROATOMS WHICH CAN BE USED AS SHP2 INHIBITOR 成都倍特药业股份有限公司 2021-06-17 — — WO disclosed
Send feedback